Day One Stock Target Price and Analyst Consensus

DAWN Stock  USD 8.12  0.58  6.67%   
The current analyst and expert consensus on Day One is Strong Buy, with 4 strong buy opinions. The current projected Day One target price consensus is 36.11 with 10 analyst opinions. Check out Macroaxis Advice on Day One to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
The most common way Day One Biopharmaceu analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Day One executives and customers to further validate their buy or sell advice. Day One buy-or-sell recommendation module provides average expert sentiment on the projected Day One Biopharmaceu target price to derive its highest and lowest estimates based on projected price volatility of 4.1064.
Lowest Forecast
32.86
Highest Forecast
40.08
Target Price
36.11
As of the 15th of March 2025, Gross Profit is likely to grow to about 132.2 M, while Pretax Profit Margin is likely to drop (0.64). At this time, Day One's Cash is very stable compared to the past year. As of the 15th of March 2025, Non Current Assets Total is likely to grow to about 21.5 M, while Total Assets are likely to drop about 306.3 M.
  
It's important to approach Day One's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Day One Target Price Consensus

Day target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Day One's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   10  Strong Buy
Most Day analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Day stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Day One Biopharmaceu, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Day One Target Price Projection

Day One's current and average target prices are 8.12 and 36.11, respectively. The current price of Day One is the price at which Day One Biopharmaceuticals is currently trading. On the other hand, Day One's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Day One Market Quote on 15th of March 2025

Low Price8.1Odds
High Price8.89Odds

8.12

Target Price

Analyst Consensus On Day One Target Price

Low Estimate32.86Odds
High Estimate40.08Odds

36.1111

Historical Lowest Forecast  32.86 Target Price  36.11 Highest Forecast  40.08
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Day One Biopharmaceuticals and the information provided on this page.

Day One Analyst Ratings

Day One's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Day One stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Day One's financials, market performance, and future outlook by experienced professionals. Day One's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Day One price targets

Day One's stock target price is an estimate of its future price, usually made by analysts. Using Day One's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Day One's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Day One's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Day One Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Day One is a key component of Day One valuation and have some predictive power on the future returns of a Day One.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Day One's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
3.667.8011.94
Details
Intrinsic
Valuation
LowRealHigh
7.3114.9419.08
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.73-0.42-0.28
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Business Services Idea
Business Services
Invested few shares
ESG Investing Idea
ESG Investing
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 60 shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested over 40 shares
Apparel Idea
Apparel
Invested over 40 shares
Casinos Idea
Casinos
Sold over 90 shares
Macroaxis Index Idea
Macroaxis Index
Sold over 90 shares
Utilities Idea
Utilities
Invested over 90 shares
When determining whether Day One Biopharmaceu offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Day One's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Day One Biopharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Day One Biopharmaceuticals Stock:
Check out Macroaxis Advice on Day One to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.